Analysts Set Colgate-Palmolive (NYSE:CL) PT at $92.94

Shares of Colgate-Palmolive (NYSE:CL – Get Free Report) have been assigned an average rating of “Moderate Buy” from the sixteen ratings firms that are presently covering the firm, Marketbeat.com reports. Three research analysts have rated the stock with a hold rating and thirteen have issued a buy rating on the company. The average 1 year […]

Leave a Reply

Your email address will not be published.

Previous post McDonald’s Loses ‘Big Mac’ Trademark Battle Against Irish Chain Supermac’s
Next post MoonLake Immunotherapeutics (NASDAQ:MLTX) Receives $74.46 Consensus PT from Brokerages